======= C17orf96 ======= == Gene Information == * **Official Symbol**: EPOP * **Official Name**: elongin BC and polycomb repressive complex 2 associated protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=100170841|100170841]] * **UniProt**: [[https://www.uniprot.org/uniprot/A6NHQ4|A6NHQ4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C17orf96&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C17orf96|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617795|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Scaffold protein that serves as a bridging partner between the PRC2/EED-EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EED-EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation. {ECO:0000250|UniProtKB:Q7TNS8}. No Pfam Domain information is available for this gene. |histone H2B conserved C-terminal lysine deubiquitination| |elongin complex| |ESC/E(Z) complex| |histone deubiquitination| |neuron fate commitment| |chromosome| |stem cell differentiation| |cell fate commitment| |protein deubiquitination| |protein modification by small protein removal| |histone modification| |covalent chromatin modification| |chromatin binding| |chromatin organization| |protein modification by small protein conjugation or removal| |neuron differentiation| |chromosome organization| |proteolysis| |generation of neurons| |neurogenesis| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.86| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.92| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 11/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|1/13| |fibroblast|0/1| |gastric|2/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|2/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11732 * **Expression level (log2 read counts)**: 4.71 {{:chemogenomics:nalm6 dist.png?nolink |}}